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Widespread Regulation of miRNA Biogenesis at the Dicer
Step by the Cold-Inducible RNA-Binding Protein, RBM3
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1 Department of Neurobiology, The Scripps Research Institute, La Jolla, California, United States of America, 2 Department of Rehabilitation Sciences, College of Health
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Abstract
MicroRNAs (miRNAs) play critical roles in diverse cellular events through their effects on translation. Emerging data suggest
that modulation of miRNA biogenesis at post-transcriptional steps by RNA-binding proteins is a key point of regulatory
control over the expression of some miRNAs and the cellular processes they influence. However, the extent and conditions
under which the miRNA pathway is amenable to regulation at posttranscriptional steps are poorly understood. Here we
show that RBM3, a cold-inducible, developmentally regulated RNA-binding protein and putative protooncogene, is an
essential regulator of miRNA biogenesis. Utilizing miRNA array, Northern blot, and PCR methods, we observed that over 60%
of miRNAs detectable in a neuronal cell line were significantly downregulated by knockdown of RBM3. Conversely, for select
miRNAs assayed by Northern blot, induction of RBM3 by overexpression or mild hypothermia increased their levels.
Changes in miRNA expression were accompanied by changes in the levels of their ,70 nt precursors, whereas primary
transcript levels were unaffected. Mechanistic studies revealed that knockdown of RBM3 does not reduce Dicer activity or
impede transport of pre-miRNAs into the cytoplasm. Rather, we find that RBM3 binds directly to ,70 nt pre-miRNA
intermediates and promotes / de-represses their ability as larger ribonucleoproteins (pre-miRNPs) to associate with active
Dicer complexes. Our findings suggest that the processing of a majority of pre-miRNPs by Dicer is subject to an intrinsic
inhibitory influence that is overcome by RBM3 expression. RBM3 may thus orchestrate changes in miRNA expression during
hypothermia and other cellular stresses, and in the euthermic contexts of early development, differentiation, and
oncogenesis where RBM3 expression is highly elevated. Additionally, our data suggest that temperature-dependent
changes in miRNA expression mediated by RBM3 may contribute to the therapeutic effects of hypothermia, and are an
important variable to consider in in vitro studies of translation-dependent cellular events.
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Introduction
MicroRNAs (miRNAs) are a family of short, noncoding RNAs
that regulate translation of mRNAs by mechanisms involving the
binding of complementary sequences [1,2]. The influence of
miRNAs on the proteome and cellular events is extensive as they
regulate an estimated 60% of the transcriptome [3] and play key
roles in differentiation, plasticity, circadian rhythm, immunity, and
disease [4–10]. The post-transcriptional biogenesis of most
miRNAs involves a sequential cleavage process mediated by
RNase III family enzymes (reviewed in ref. [11]). Primary
transcripts (pri-miRNAs) are first cleaved by Drosha in the
nucleus to yield ,70 nt hairpin precursors (pre-miRNAs). These
intermediates are transported to the cytoplasm where ,22mer
dsRNAs are excised by Dicer. Typically, one strand of the dsRNAs
is inserted as a mature miRNA into the RNA-induced silencing
complex (RISC), which contains members of the Argonaute (Ago)
protein family that contribute to translational regulation [12,13].
Recent studies indicate that some RNA-binding proteins (RNA-
BPs) can regulate discrete processing steps [3], differentially
blocking [14,15] or promoting [16–18] the formation of specific
miRNAs to control cellular proliferation and differentiation.
Elegant examples of this mechanism include the attenuation of
let-7 biogenesis in embryonic stem cells by the pluripotency factor
LIN28 [15,19], and the selective enhancement of miR-18a
biogenesis from a polycistronic transcript by hnRNPA1 [16].
RBM3 is a member of a small, highly conserved family of RNA-
BPs that is upregulated in response to mild hypothermia [20].
Members of this family have been proposed to play an adaptive
role by acting as mRNA chaperones that preserve translation
capacity, or enhance translation rates upon restoration of
euthermic conditions [21–23]. RBM3 is ubiquitously expressed
and it is the only transcript upregulated in all tissues during torpor
[21]. Upregulation of RBM3 also occurs in response to other
cellular stressors, such as hypoxia and degenerative conditions,
where it may attenuate both apoptosis and necrosis [24,25].
Increased expression of RBM3 has been noted in several cancer
cell types where it has been proposed to act as a protooncogene
that facilitates cell division and attenuates apoptosis [26]. Under
normal physiological conditions, RBM3 is developmentally
regulated in brain, and in the adult brain it is highly expressed
in progenitor cell fields and other regions with high cerebral
translation rates [27]. Taken together, these observations suggest
that RBM3 may have a fundamental function in all cells that
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becomes of adaptive value under conditions of cellular stress, and
of pathological significance in cell transformation. In prior work,
we demonstrated that overexpression of RBM3 in neuronal cell
lines reduces the levels of a miRNA-containing ribonucleoprotein
(miRNP) peak resolved on sucrose gradients [22,23]. This
observation suggested that the functions of RBM3 - in stress
adaptation, normal physiology, and potentially in oncogenesis –
may involve the miRNA pathway.
In the present study, we demonstrate that RBM3 regulates the
posttranscriptional biogenesis of a majority of miRNAs at the
Dicer step. We present evidence that it does this by binding
,70 nt miRNA precursors and promoting their ability to engage
catalytically active Dicer complexes. The significance of our
findings is discussed in terms of how pre-miRNAs are regulated as
larger ribonucleoprotein complexes, and in terms of the set of
physiological conditions that may influence the miRNA pathway
through induction or suppression of RBM3 expression.
Results
Microarray profiling reveals broad and differential effects
of RBM3 on miRNA expression
To characterize the influence of RBM3 on the miRNA
pathway, we began by analyzing miRNA expression profiles after
siRNA-mediated knockdown of RBM3 in the B104 neuronal cell
line. Using Agilent miRNA arrays encompassing all known mouse
miRNAs, we observed that a .90% reduction of RBM3 (Figure
S1) resulted in extensive and differential changes in miRNA
expression: 129 were reduced, while 30 were increased (Figure
1A, Table S1). The set of 159 miRNAs exhibiting significant
expression changes comprised 74% of the total number of
miRNAs detected (216) above background threshold in B104
cells. Within this set were miRNAs previously implicated in
proliferation and migration (e.g. miR-9 [28]), differentiation (e.g.
the let-7 family [29]), synaptic plasticity (e.g. miR-134 [30]),
apoptosis (e.g. miR-29b [31]), oncogenesis (e.g. the miR-17-92
cluster [7,8]) and other functions. Expression changes identified by
microarray were reliably confirmed in Northern blot analyses in
which we also evaluated the effects of RBM3 overexpression.
Representative Northern blots for miR-16, let-7g, and miR-1224
are shown in Figures 1B and 2A (with additional examples in
Figures S2, S3). These assays revealed that knockdown and
overexpression of RBM3 had opposite effects on miRNA
expression. Levels of miR-16 and let-7g, for example, varied
positively with the level of RBM3, while miR-1224 showed the
opposite pattern. Group Northern blot data summarizing the
differential and bidirectional regulation of 11 miRNAs by RBM3
is shown in Figure 1C.
miRNAs showing significant down regulation by microarray
analysis were consistently validated by Northern blot. However,
changes in miRNAs that by microarray analysis were elevated after
RBM3 knockdown – 30 in total – were harder to validate. In the
case of miR-1224, which is predicted to be a mirtron [32,33] and
thus processed along a pathway that does not require Drosha, large
increases were validated by Northern blot. Others in the set of 30
miRNAs elevated in array analyses after RBM3 knockdown were
either more variable or harder to detect in Northern blot assays.
Those with very low expression may be subject to false positive
variation, which would indicate that an even greater majority of the
miRNA pool varies directly with RBM3 expression levels.
Figure 1. RBM3 modulates miRNA expression. (A) Heat map representing the top 50 significant miRNA expression differences between control
(con) and RBM3 knockdown (si) B104 cells. (B) Northern blots of select miRNAs under con, si, and RBM3 overexpression (o/x) conditions; 5S RNA,
loading control. (C) Group Northern blot data for RBM3-associated changes in 11 miRNAs, each normalized to 5S RNA (n = 3–5 independent
experiments; * p,0.05, ** p,0.01, 1-tailed t-test).
doi:10.1371/journal.pone.0028446.g001
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Physiological induction of RBM3 by mild hypothermia
enhances let-7 biogenesis in a RBM3-dependent manner
Experimental overexpression of RBM3 increased the levels of
many miRNAs, and physiological induction of RBM3 by mild
hypothermia [20] recapitulated this effect. Incubation of B104
cells at 32uC for 24 hours resulted in upregulation of mature let-7g
(Figure 2A) and other miRNAs (Figure S3). The enhancement
of let-7g steady state levels at 32uC was blocked by knockdown of
RBM3, suggesting that induction of the RNA-BP was absolutely
required for hypothermia related upregulation of let-7g (Figure
2B). These observations suggest that adaptation to cold stress may
involve RBM3-mediated regulation of the miRNA pathway.
Knockdown of RBM3 selectively impairs the processing
of pre-miRNAs at the Dicer step
We next investigated the mechanisms by which RBM3 regulates
miRNA biogenesis. RBM3 has a relatively simple domain
structure, being comprised of a single RNA-recognition motif
(RRM) and a c-terminal region rich in arginine, glycine, and
tyrosine. Because many RNA-BPs harboring these domains
(particularly hnRNPs) regulate multiple aspects of RNA metabo-
lism, we considered that RBM3 may act at several steps in the
process of miRNA biogenesis, including transcription, splicing,
transport, and stability. In addition, recent studies on the roles of
the RNA-BPs hnRNPA1, LIN28, and KSRP in the biogenesis of
specific sets of miRNAs have demonstrated that post-transcrip-
tional cleavage of pre-miRNAs can also be regulated [15–17]. To
begin evaluating these possibilities, we used RNA probes to
measure levels of mature miRNAs and their precursor species by
Northern blot. Northern blots of mature let-7i and its pre-miRNA
revealed that, concomitant with reduction of mature 22mers, there
was an accumulation of ,70 nt pre-miRNAs after RBM3
knockdown (Figure 3A). This pattern was evident for all other
miRNAs examined by Northern blot (e.g. Figures S1, S2, S3).
Elevated levels of pre-miRNAs after RBM3 knockdown were also
seen by Northern blot when probes complimentary to the full
length sequence of the precursor were used (Figure S2). To
confirm this result using another method, we performed semi-
quantitative RT-PCR (Figure 3B) and quantitative RT-PCR
(qRT-PCR), both of which showed large elevations in pre-
miRNAs after RBM3 knockdown. The accumulation of pre-
miRNAs after RBM3 knockdown was reproducible in other cell
lines. In HEK 293T and HeLa cells, the processing of pre-let-7a to
mature let-7a was greatly attenuated under conditions of reduced
RBM3 expression (Figure 3E) and accompanied by large
increases in this precursor.
In contrast to pre-miRNAs, the levels of primary transcripts did
not appear to change after RBM3 knockdown, suggesting that
accumulation of ,70 nt pre-miRNAs was not simply due to an
increase in transcription of pri-miRNA Drosha substrates. This
pattern, reminiscent of pre-miRNA accumulation when Dicer is
inactive or absent [34], is seen on Northern blots of miR-132 for
which both the pri- and pre-miRNA species are readily resolved
on a single gel (Figure 3C). The large and selective increases in
pre-miRNAs that we observed by Northern blot (and RT-PCR)
after RBM3 knockdown did not involve changes in tRNAs that are
of approximately the same size as pre-miRNAs and have hairpin
structures (Figure 3D and Figure S3). Neither did it appear that
the effects of RBM3 on pre-miRNAs could be due to altered
splicing. While a Drosha-independent mechanism has been
identified for the formation of pre-miRNAs that involves splicing
of some intron-positioned miRNAs (mirtrons [32,33]), this applies
to a relative few primary transcripts and the genomic locations of
the vast majority of RBM3-regulated miRNAs are not suitable for
this pathway.
It is noteworthy that in our Northern blot studies of miRNA
expression in B104 cells the relative levels of pre-miRNAs
compared to mature ,22mers was higher than often seen. Given
that changes in pre-miRNA levels following RBM3 knockdown
were confirmed by three different approaches, and that tRNAs are
not affected by manipulation of RBM3, it is likely that ratios of
pre-miRNAs to mature ,22mers vary with cell type. Consistent
with this idea, our own studies using HeLa and HEK293 cells
(Figure 3E) reveal different ratios of pre-miRNAs to mature
,22mers at steady state compared the B104 neuronal cell line and
to each other. This may reflect different basal rates of pre-miRNA
processing in different cell lines. Even with such differences in
steady state processing, knockdown of RBM3 had the same effect
in all cell lines tested: it caused selective accumulation of pre-
miRNAs. This effect appeared greatest in HEK293 cells, where
the steady state ratio of pre-miRNA to mature ,22mer was the
lowest of the three cell lines tested.
Knockdown of RBM3 does not impair transport of
pre-miRNAs into the cytoplasm
One plausible basis for the correlated changes in miRNAs and
their parent pre-miRNAs is that RBM3 knockdown leads to a
deficit in the transport of pre-miRNAs to the cytoplasm where
they become a substrate for Dicer. However, while our prior work
[23,27] demonstrated that RBM3 can traffic between nuclear and
cytoplasmic compartments, analysis of the subcellular distribution
of pre-let-7g by Northern blot (Figure 3F) and in situ
hybridization (Figure 3G) did not reveal deficits in cytoplasmic
transport of the precursor when RBM3 was depleted. Rather, pre-
miRNAs accumulated in the cytoplasm after RBM3 knockdown.
There was no obvious change in mature let-7 localization after
RBM3 knockdown (Figure 3G). Some nucleolar hybridization
Figure 2. Induction of RBM3 by mild hypothermia mimics the
effects of RBM3 overexpression on let-7g levels. (A) Upper
panels: Northern blots of let-7g in control (con), RBM3 knockdown (si),
RBM3 overexpression (o/x), and mildly hypothermic (32uC624 hrs)
conditions. 5S RNA is the loading control. Lower two panels: Western
blots of RBM3 in the four conditions; b-actin is the loading control. (B)
Upper panels: Northern blot of let-7g in control and RBM3 knockdown
B104 cells maintained at normal (37uC) and mildly hypothermic (32uC)
conditions; 5S RNA is the loading control. Lower panels: Western blot
showing induction of RBM3 at 32uC in controls, but greatly attenuated
expression at both temperatures in the siRNA condition. b-actin is the
loading control. Enhanced expression of let-7g at 32uC is prevented
when RBM3 is knocked down.
doi:10.1371/journal.pone.0028446.g002
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was seen, consistent with reports that several miRNAs are present
in this compartment [35].
Knockdown of RBM3 does not lead to reduced Dicer
activity or to modifications in pre-miRNAs that impair
their ability to act as Dicer substrates
In light of the aforementioned findings, a logical hypothesis for
the effects of RBM3 on the expression of miRNAs is that it
modulates the posttranscriptional processing of pre-miRNAs by
Dicer. In principle, this could involve changes in the Dicer
complex, modification of pre-miRNAs, or the interaction of these
entities. As RBM3 is known to promote the stability of some
mRNAs [26] and overall translation [22,23], a straightforward
hypothesis is that levels of Dicer are reduced by RBM3 depletion.
Unexpectedly, however, expression of Dicer was significantly
elevated after RBM3 knockdown (Figure 4A, B). In accord with
this observation, Dicer-mediated processing of a synthetic version
of pre-let-7g was actually greater in lysates from RBM3
knockdown cells than in control lysates (Figure 4C). We next
looked for deficits in two cofactors of Dicer involved in pre-
miRNA processing and insertion of mature miRNAs into the
RISC complex: the transactivator responsive RNA binding
protein 2 (TRBP) and Ago2 [13,36]. However, Ago2 was also
Figure 3. Pre-miRNA processing is selectively impaired by knockdown of RBM3. (A) Northern blot of let-7i showing relative levels of
mature and pre-miRNA species in B104 cells under control (con) and RBM3 knockdown (si) conditions; 5S RNA, loading control. (B) Upper panel:
Ethidium bromide stained gel showing pre-let-7g products from semi-quantitative RT-PCRs using control and RBM3 knockdown B104 cell RNA
templates; GAPDH was used as a control. Lower panel: Graph illustrating fold increase in pre-let-7g after RBM3 knockdown as measured by
quantitative RT-PCR (qRT-PCR; n = 3, p,0.01); U6 was used as the internal reference. (C) Northern blot of miR-132 showing the relative levels of pri-
and pre-miR-132 species in control and RBM3 knockdown conditions. 5S RNA, loading control. (D) Upper panel: Northern blot of the same samples
using a probe for tRNA-Gly. Lower panel: Ethidium bromide (EtBr) visualization of tRNAs. (E) Northern blots of let-7a in HEK 293T and HeLa cells
showing attenuated processing of pre-let-7a after RBM3 knockdown. (F) Northern blot of let-7g in nuclear and cytoplasmic fractions from B104 cells;
pre-let-7g accumulates in the cytoplasm after knockdown of RBM3. (G) In situ hybridization with probes selective for pre-let-7g (top panels) and
mature let-7g (lower panels) in B104 cells under con and si conditions.
doi:10.1371/journal.pone.0028446.g003
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expressed at significantly higher levels when RBM3 was depleted,
while TRBP exhibited little change (Figure 4A, B). These effects
were also seen in HeLa cells (Figure S4). These results did not
support the idea that reduction of RBM3 levels leads to an
insufficiency of Dicer complexes that would impair pre-miRNA
processing. However, they may be consistent with downstream
effects of RBM3-related changes in miRNA expression. A number
of miRNAs predicted to target messages encoding Dicer complex
components are reduced after RBM3 knockdown, and it has been
reported that Dicer is subject to feedback regulation by let-7 [37].
We observed that all let-7 family members were reduced after
RBM3 knockdown (Table S1; Figure 2, Figures S1, S2, S3).
This suggested that known targets of let-7, including Dicer, would
be upregulated even though reductions of RBM3 lead to
decreased overall translation [23]. Consistent with this idea, we
observed an increase in the expression of another let-7 target, k-ras
[38], by Western blot after knockdown of RBM3 (Figure 4D).
In contrast to the effects of RBM3 knockdown in B104 cells,
overexpression of the RNA-BP had no effect on Dicer or Ago2
levels and significantly decreased the expression of TRBP (Figure
4A, B). These results suggested that the enhanced biogenesis of
many miRNAs seen when RBM3 is overexpressed does not rely
on increases in Dicer complex levels or activity. Dicer and Ago2
were modestly decreased by this manipulation in HeLa cells
(Figure S4).
Knockdown of RBM3 does not alter the ability of
pre-miRNAs to act as Dicer substrates
Altered pre-miRNA processing in the context of low RBM3
levels could also stem from modifications of precursors that alter
their ability to act as Dicer substrates. Precedent for such a
mechanism comes from the inhibitory effect of LIN28 on the
processing of let-7 family members, which involves polyuridylation
of precursors [39,40]. As a general test of this possibility, we
purified endogenous small RNAs (,60 nt to ,100 nt) from
control and RBM3 knockdown cells and end-labeled them so that
their processing could be visualized after re-incubation with
cytosolic extracts from each condition (Figure 4E). Purified
,70 nt RNAs from control and siRNA-treated cells were
efficiently processed by both cellular extracts into mature
miRNAs. There appeared to be an enhanced processing of
,70 nt RNAs isolated from RBM3 knockdown cells by each
extract (relative to control ,70 nt RNAs); this may be due to a
greater proportion of pre-miRNAs in the ,70 nt pool of RNAs
isolated from RBM3 knockdown cells. As a control for general
RNase activity, end-labeled RNAs of ,100 nt were not processed
by either extract. Combined with the lack of an obvious size
change in electrophoretically resolved pre-miRNAs (Figure 3A–
C, Figures S1, S2, S3), these observations suggest that low
RBM3 expression does not result in primary structural modifica-
tions of pre-miRNAs that impair their cleavage by Dicer.
Evidence for a role of RBM3 in directly regulating
pre-miRNA ribonucleoprotein complexes
While lowering RBM3 expression impaired the processing of
many endogenous pre-miRNAs, exogenously added precursors
(synthetic or purified endogenous) were nevertheless processed
efficiently in this condition. We hypothesized that endogenous and
exogenous precursors differ in their ability to access Dicer, perhaps
because exogenous precursors do not acquire key factors that
Figure 4. Knockdown of RBM3 does not reduce Dicer complex components or the ability of pre-miRNAs to act as substrates. (A)
Western blots of Dicer, Ago2 and TRBP in B104 cells under control (con) conditions, and after knockdown (si) and overexpression (o/x) of RBM3. b-
actin is the loading control. (B) Bar graph summarizing changes in Dicer (n = 4), Ago2 (n = 5), and TRBP (n = 3); * p,0.01, 2-tailed paired t-test. (C)
Northern blots showing the processing of a synthetic pre-let-7g by cytosolic lysates from con, si, and o/x conditions. (D) Bar graph and example
Western blot showing levels of the let-7 target, k-ras, in con and si conditions (* p,0.05, 1-tailed paired t-test, n = 3). b-actin is the loading control. (E)
Autoradiographs showing the processing of endogenous small RNAs of ,100 nt and ,70 nt that were purified from B104 cells under control (con)
and si conditions, end labeled, and then re-incubated with cell extracts from the indicated treatment conditions.
doi:10.1371/journal.pone.0028446.g004
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normally limit such interactions. As expected from our in vitro
processing data and Dicer expression results, the association of
Dicer, TRBP, and Ago2 with biotinylated pre-miRNA probes (let-
7i and miR-16) was actually enhanced after knockdown of RBM3
(Figure S5). To evaluate whether reduced RBM3 expression
causes endogenous pre-miRNAs to acquire a distinct set of factors,
we used sucrose gradient fractionation assays optimized to resolve
low molecular weight (MW) pre-miRNPs and complexes contain-
ing TRBP and Ago2 (Figure S6A, B). As measured by
continuous A260 RNA readings through the gradients, knockdown
of RBM3 altered the profile of low MW RNPs and translation
machinery. In fractions 1 – 9 from the early RNP portion, TRBP
and Ago2 co-sedimented and their distribution peaked in the same
fraction (#6) in controls and RBM3 siRNA conditions (Figure
5A). However, the distribution of pre-miRNAs was altered by
knockdown of RBM3. Northern blots of pre-let-7g in gradient
fractions revealed that precursors accumulating after RBM3
knockdown distribute to complexes of lower MW than TRBP/
Ago2-containing complexes (Figure 5A, Figure S6B). In
controls, mature let-7g was also detected, along with decreasing
amounts of pre-let-7g, in TRBP/Ago2-containing fractions,
suggesting that these are active processing complexes (Figure
5A). However, mature let-7g was not detected in TRBP/Ago2-
containing fractions under RBM3 knockdown conditions, even
though these fractions contained some pre-let-7g and exhibited
more Dicer activity towards exogenous pre-let-7g (Figure 5B).
These data suggest that reduced RBM3 expression results in the
association of pre-miRNAs with a lower MW complex of factors
that attenuate interactions with Dicer. Alternatively, RBM3 may
itself facilitate pre-miRNP association with Dicer, but this would
have to be reconciled with the enhanced processing of exogenous
pre-miRNAs by RBM3 knockdown cell lysates.
The effects of RBM3 on pre-miRNA processing may arise from
direct interactions between RBM3 and precursors, analogous to
what has been shown for LIN28, hnRNPA1, and KSRP [15–19].
To test this, we immunoprecipitated RBM3 and probed for pre-
let-7g and pre-miR-16 by RT-PCR. Both of these precursors were
amplified from the RBM3 immunoprecipitates, but not from IgG
control precipitates or from samples in which reverse transcriptase
was omitted (Figure 6A and Figure S7); b-tubulin mRNA was
tested as a negative control (Figure 6B). In addition, electropho-
retic mobility shift assays showed that RBM3 binds pre-let-7g and
pre-miR-16 probes directly in vitro (Figure 6C); 18S RNA was
used as a negative control in these assays (Figure 6D). Consistent
with the idea that RBM3 may regulate pre-miRNP access to Dicer
complexes, the processing of endogenous pre-let-7g by cytoplasmic
extracts from RBM3-depleted cells was partially rescued by acute
addition of recombinant RBM3 (Figure 6E). Addition of
exogenous RBM3 to extracts from cells in which endogenous
RBM3 had been knocked down led to a decrease in pre-let-7g
levels, with a concomitant increase of the dsRNA miRNA duplex.
These data suggest that RBM3 binds directly to pre-miRNAs to
regulate their processing by Dicer.
Discussion
Our data establish a novel role for RBM3 in the posttranscrip-
tional regulation of miRNA biogenesis, one with important
implications for how pre-miRNAs are regulated as RNPs. The
majority of miRNAs affected by RBM3 knockdown were
downregulated, leading to accumulation of endogenous pre-
miRNAs even as Dicer activity remained at or above normal
levels against exogenous substrates. We observed that RBM3
associates with pre-miRNAs in vitro and in situ, suggesting that it is
an integral part of larger pre-miRNA ribonucleoprotein complexes
(pre-miRNPs). Taken together, these findings suggest that RBM3
regulates the competency of a large proportion of pre-miRNPs to
engage catalytically active Dicer complexes. This is consistent with
our observation that, in sucrose gradient fractionation assays,
knockdown of RBM3 leads to accumulation of pre-miRNAs as
lower MW species. A plausible model for these effects is that
integration of RBM3 into pre-miRNPs displaces an inhibitory
factor from pre-miRNAs that normally attenuates their processing
by Dicer (Figure 7). Our data favor this de-repression model over
one in which RBM3 directly facilitates association of pre-miRNPs
with Dicer complexes because exogenous pre-miRNAs are rapidly
and efficiently processed by extracts from RBM3 depleted cells. In
any case, our results support the broader notion that miRNA
Figure 5. RBM3 regulates pre-miRNP composition. (A) Northern and Western blots showing the distribution of pre-let-7g, mature let-7g, TRBP,
Ago2, and RBM3 in early (RNP) fractions from sucrose gradients of control and RBM3 siRNA-treated B104 cells. Fraction 6 (red) represents the peak of
TRBP and Ago2 distribution in both conditions; pre-let-7g accumulates as a lower molecular weight pre-miRNP complex in the siRNA condition.
Mature let-7g is present in TRBP / Ago2-containing fractions from control cells, but barely detectable in the same fractions from RBM3 knockdown
cells. (B) Autoradiogram showing processing of labeled synthetic pre-let-7g in concentrated samples from the TRBP/Ago2-containing fractions of
control and RBM3 knockdown conditions. Processing activity towards an exogenous precursor is still intact in the knockdown condition, even as
processing of the endogenous pre-let-7g is greatly attenuated.
doi:10.1371/journal.pone.0028446.g005
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biogenesis is differentially regulated by the coordinated effects of
many RNA-BPs acting at the level of pre-miRNP formation [3].
The fact that 60% of all miRNAs detected by microarray in B104
cells were downregulated after depletion of RBM3 suggests that
RBM3 is a component of most pre-miRNPs. How RBM3 modifies
the composition of pre-miRNPs is currently under study.
Our results also bear on the nature of cellular conditions that
influence the miRNA pathway via RNA-BPs. Although cold
exposure is among the most basic and ubiquitous challenges to
living organisms – and an essential aspect of torpor – the cellular
responses to this stress are poorly understood. What is clear,
however, is that cold exposure can elicit cellular changes that are
protective or that limit pathological processes after a physiological
insult or trauma [41]. This effect has been exploited clinically in
the areas of therapeutic hypothermia during surgery, after spinal
chord injury, in traumatic brain injury and stroke, and in organ
transplant [41–43]. Recent reports indicate that induction of
RBM3 is essential for the protective effects of hypothermia in
models of perinatal asphyxia [44] and muscle wasting [45]. The
present data and our prior work [22,23] together suggest that a
coordinated regulation of miRNA biogenesis and global transla-
tion rates by RBM3 are part of the adaptive process to cold
exposure. These molecular functions of RBM3 may contribute
directly to the protective effects of hypothermia observed in many
paradigms. RBM3 is also induced by other physiological stressors
[24], and is upregulated in various cancer types [26] and
degenerative states [25,44], potentially coupling these conditions
to changes in miRNA expression.
The set of miRNAs regulated by RBM3 includes many with
previously established roles in oncogenesis. It has been proposed
elsewhere that RBM3 is a protooncogene that blocks apoptosis
and enhances proliferation [26]. Moreover, it has been demon-
strated that reduction of RBM3 expression – and expression of the
highly homologous cold-inducible RNA binding protein (CIRP) –
by heat shock impairs the survival of cancer cells and increases
their sensitivity to chemotherapeutic compounds [46]. It is
reasonable to speculate, then, that the pro-survival functions of
RBM3 in cancer cells, and the therapeutic effects of downregu-
lating RBM3 by heat shock, may involve its activity on miRNAs
that have previously been linked to oncogenesis (e.g. the miR-17-
92 cluster [7,8]). However, there is also emerging evidence that
very high expression of RBM3 within the nuclear compartment in
some cancer types is a positive predictor of clinical outcome [47].
This may reflect a different role of nuclear-retained RBM3, or
perhaps a change in the expression of key miRNAs (such as those
targeting RBM3-regulated checkpoint proteins [47]) at higher
RBM3 concentrations.
RBM3 is also dynamically expressed as part of normal
physiology during early brain development [27]. In this context,
the effects of RBM3 on miRNAs involved in neural differentiation
may be significant given that the RNA-BP is highly expressed in
multiple brain regions during an early postnatal period, and
remains especially high in neural progenitor fields in adulthood
[27]. Of particular interest is the finding that RBM3 enhances the
biogenesis of all members of the let-7 family, which are involved in
neural differentiation [19,29]. In embryonic stem cells, the
processing of let-7 family members is known to be blocked at
the Dicer step by LIN28 to maintain pluripotency, and this
blockade is negatively regulated by a feedback influence of let-7
and miR-125a [19]. It will be of interest to determine if RBM3
opposes the effects of LIN28 by facilitating negative feedback at an
early stage in neural commitment.
Given the range of conditions under which RBM3 is strongly
induced, the data we have obtained here concerning its effects
Figure 6. RBM3 associates with pre-miRNAs. (A) Gel showing pre-let-7g RT-PCR product amplified from immunoprecipitate (IP) and post-IP
input fractions in the following conditions: no treatment (con), IP with pre-immune IgG (IgG), IP with 5 mg and 10 mg of affinity purified anti-RBM3
antibody (a-RBM3-5/10). (B) Negative control RT-PCR for b-tubulin. (C) Autoradiographs of labeled pre-let-7g and pre-miR-16 resolved on non-
denaturing gels after incubation with increasing amounts of purified recombinant RBM3 in electrophoretic mobility shift assays. (D) Negative control
gel shift using 18S RNA. (E) Northern blot showing partial rescue of endogenous pre-let-7g processing in RBM3 knockdown (si) cell lysates by
addition of recombinant RBM3 to in vitro processing reactions. 5S is loading control.
doi:10.1371/journal.pone.0028446.g006
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on miRNA biogenesis suggest that RBM3 may be a critical
regulator of miRNA-dependent events involved in adaptive,
developmental and pathophysiological processes. Further mech-
anistic studies may unveil additional factors that participate with
RBM3 in fine tuning miRNA biogenesis responses to particular
cellular or developmental conditions. In addition, clinically
important insights into the mechanisms of therapeutic hypother-
mia may emerge from target analyses of RBM3-regulated
miRNAs.
Materials and Methods
Manipulation of RBM3 levels
Our studies utilized B104 neuroblastoma [48], HeLa and HEK
293T (ATCC) cell lines. Cell lines were transfected with the siRNA
(si) duplex listed in Table S2 at a ratio of 20 nM siRNA per 25 ml
RNAiMax to knockdown RBM3, or pcDNA3.1-RBM3 to over-
express the protein using Lipofectamine reagents (Life Technolo-
gies); cells were harvested after 48 hrs. For cold-shock (CS)
Figure 7. Model of the effects of RBM3 on the posttranscriptional regulation of miRNA biogenesis. (A) Pre-miRNAs exist as two or more
pools of pre-miRNPs that contain distinct factors (A and B) mediating association with Dicer complexes. One class also binds a factor (X) that inhibits
association with Dicer complexes, and is displaceable by RBM3. In the context of low RBM3 levels – such as occurs during RBM3 knockdown, heat
shock, and in most cells during later stages of development – miRNA biogenesis is biased towards pool B, which lacks factor ‘‘X’’ and thus has greater
access to Dicer. Not shown in this model are the increases in Dicer and Ago2 levels that occur during RBM3 knockdown, which may also facilitate the
processing of pre-miRNAs not bound by an inhibitory factor. (B) In the context of high RBM3 levels – such as occurs during mild hypothermia,
oncogenesis, early development, hypoxia, degenerative disesease, and early development – the inhibitory factor is displaced from pool A by the
binding of RBM3 to pre-miRNAs. RBM3 binding thus derepresses pre-miRNAs in pool A and enhances their access to Dicer complexes, and
subsequent processing. Access of pre-miRNAs that do not bind RBM3 (pool B) to Dicer is reduced by competitive exclusion.
doi:10.1371/journal.pone.0028446.g007
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induction of RBM3, B104 cells were placed at 32uC for 24 hours.
The B104 cell line was used in miRNA array profiling studies.
MicroRNA array profiling
The mirVana miRNA isolation kit was used to isolate miRNAs.
miRNA array profiling utilized the mouse miRNA microarray
from Agilent Technologies (G4472A), which is selective for mature
miRNAs; hybridization was done according to their specifications.
Microarrays were scanned and analyzed with the Agilent scanner
and Genespring software.
The Agilent Feature Extraction tool was used to obtain the
signal values and detection above background for the Agilent chip.
Processing of the data was performed within the Bioconductor
project and the R program software (R is available as Free
Software under the terms of the Free Software Foundation’s GNU
General Public License). The scale normalization method used
was proposed by Yang et al. [49,50] and is further elaborated by
Smyth and Speed [51]. Log-values were scaled to have the same
median-absolute-deviation (MAD) across arrays. The 578 Human
miRNAs were filtered down to 216 by excluding those miRNAs
with signals not detected above background for all the samples.
The fold changes and standard errors were estimated by fitting a
linear model with allowance for paired samples for each gene and
empirical Bayes smoothing was applied to the standard errors for
all the samples at the same time. The linear modeling approach
and the empirical Bayes statistics as implemented in the Limma
package in the R software were employed for differential
expression analysis. Statistics were obtained for transcripts with
the multiple testing adjusted (Benjamini-Hochberg) p-values level
of 0.05. MicroRNA array data are MIAME compliant and have
been deposited in the GEO database (accession # pending).
Northern blotting
Per treatment condition, 10 mg of total RNA was resolved on a
15% TBE-urea gel, transferred to a nylon membrane (250 mA for
1.5 hours), then cross-linked with UV. Radiolabeled RNA probes
(106 cpm/ml) were hybridized at 42uC overnight. Membranes
were washed and exposed to X-ray film.
Western blotting
Samples were lysed in a buffer composed of 1% triton X-100,
1 mM Tris-HCl (pH 7.4), 150 mM NaCl, and protease inhibitor
cocktail (Roche), then boiled in NuPage SDS Buffer (Life
Technologies) and resolved on 4–12% tris-glycine gels for immuno-
blotting with antibodies against RBM3 (1:2000, made in house), b-
actin (1:10,000 Sigma), Ago2 (1:1000 Abnova), Dicer (1:1000
Abnova), and ribosomal protein S20 (1:1000, made in house).
Sucrose gradient centrifugation analysis of pre-miRNPs
and translation machinery
A total of 26107 B104 cells were lysed with ice-cold buffer A:
20 mM Tris, pH 7.4, 100 mM KCl, 10 mM MgCl2, 0.5 mg/ml
heparin, 2 mM DTT, protease inhibitor cocktail (Roche), 100 mg/
ml cycloheximide (Sigma), and 0.3% Igepal-600 (Sigma). Cyto-
plasmic extracts were obtained after centrifugation at 30,000 x g
for 15 min at 4uC, loaded onto a linear gradients of 10–50% (to
broadly resolve translation machinery) or 15–55% (for finer
resolution of pre-miRNP complexes) sucrose in buffer A, and
centrifuged at 100,000 x g for 3 h, or 30,000 x g for 18 h (4uC),
respectively. A continuous reading of RNA distribution through
the gradients was obtained by upward displacement of the sucrose
with purdenz (Accurate Chemical & Scientific Corporation)
through an ISCO UA-6 UV monitor reading absorbance at
260 nm. Half milliliter fractions were collected through the entire
(11 mL) gradients and analyzed by Northern and Western
blotting. Protein was precipitation by the TCA/acetone method
and RNA was isolated from sucrose gradient fractions with Trizol
LS according to manufacturer protocol (Life Technologies).
In Situ Hybridization
B104 cells grown on glass coverslips were fixed with 4%
paraformaldehyde, and in situ hybridization was performed as
previously described [52] with 20 ng of 59-DIG-labeled LNA
hybridization probes complementary to mouse mature let-7g and
pre-let-7g (Exiqon). Fluorescent images were collected on a Zeiss
LSM 710 laser scanning confocal microscope (LSCM).
Electrophoretic Mobility Shift Assay
A 32P-labeled precursor transcript (125 fmol of either pre-let-7g,
pre-miR-16, or 18S RNA) was incubated alone or with increasing
concentrations of rRBM3 (ranging from 30 ng to 300 ng) in the
following buffer: 5 mM Tris (pH 7.4), 12.5 mM NaCl, 0.05 mM
EDTA, 0.05 mg/ml tRNA, 0.05 mg/ml heparin and 0.01%
Igepal in a total volume of 10 ml. The reactions were incubated at
4uC for 30 min, and then 2.8 ml of RNA loading dye was added to
each reaction and separated on a 5% native Tris-glycine
polyacrylamide gel.
Preparation and purification of RNA probes
Northern probes were in vitro transcribed and labeled with
[c-32P] UTP according to the mirVana miRNA Probe Construc-
tion kit protocol (Life Technologies) and purified on 15% TBE-
acrylamide gels. The gel shift probes were prepared similarly with
the T7 MegaShortscript kit (Life Technologies). All 32P-labeled
RNA transcripts were purified on 15% TBE-acrylamide gels. The
synthetic pre-let-7g transcript used in processing assays was
prepared cold with T7 MegaShortscript (Life Technologies) for
59-labeling. To prepare endogenous precursors for processing
assays, total isolated RNA was run on a 15% TBE-polyacrylamide
gel and bands corresponding to oligonucleotides of 50–100 nt in
length were excised and purified from the gel. Elution was carried
out overnight with Probe elution buffer (Life Technologies). The
eluate was then precipitated using 3 volumes of 100% ethanol. In
end-labeling experiments, the 59 phosphate groups were removed
by using alkaline phosphatase (New England Biolabs) for 1h at
37uC, followed by phenol/choloroform purification and ethanol
precipitation. The purified RNAs were 59 end-labeled with [c-32P]
ATP by using polynucleotide kinase (New England Biolabs).
Following labeling, RNAs were once again resolved on 15% TBE-
polyacrylamide gels and the major bands ,70 nt and ,100 nt
were excised and gel purified. The biotinylated pre-let-7g and pre-
mir-16 used in pulldown experiments were transcribed with the
T7 MegaShortscript (Life Technologies) with the addition of
7.5 mM Biotin-AG (Thermoscientific) to the transcription mix,
followed by column purification. Oligonucleotides used for the T7
RNA polymerase reactions are shown in Table S2.
Subcellular RNA fractionation
Subcellular fractionation and extraction of RNA was performed
with the mirVana PARIS kit (Life Technologies), followed by
Northern blot analysis.
Pre-miRNA processing assays
Processing assays were performed as described previously [53]
with a few alterations. Cell extracts were lysed in 30 mM Hepes,
pH 7.4, 100 mM KCl, 5 mM MgCl2, 10% glycerol, 0.5 mM
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DTT, 0.1 U/ml RNase OUT (Life Technologies), and protease
inhibitors (Roche). Lysed samples were sonicated and centrifuged
at 4uC, 13,000 rpm. Dicer-complex enriched sucrose gradient
fractions were concentrated with Amicon Ultra 10K centrifugal
filters (Millipore), and the final protein concentration determined
by Bradford (Bio-Rad). A volume of the resulting concentrates
containing 10 mg of protein was adjusted such that the following
buffer components were present at the indicated final concentra-
tions: 5 mM ATP, 7.5 mM MgCl2, 0.5 U RNase OUT (Life
Technologies), 0.256105 cpm of the labeled synthetic precursor.
The reaction was set up on ice and incubated for 45 min at 37uC.
Samples were boiled for 1 min at 95uC and loaded on a 15%
denaturing TBE-urea polyacrylamide gel (Life Technologies) and
exposed to X-ray film. The same final buffer and reaction
conditions were used in assays of the processing of labeled
endogenous pre-miRNAs by B104 cytoplasmic extracts. For
processing assays utilizing total cell extracts, lysates were prepared
as described above and readjusted to 10 mg/ml.
Immunoprecipitation of RBM3-miRNA-containing
complexes and RT-PCR
Cell extracts were prepared according to the Magna-RIP RNA-
binding protein immunoprecipitation kit protocol (Millipore).
Samples were immunoprecipitated with 5 mg of anti-Rabbit IgG
as a control or 5–10 mg of anti-RBM3 antibody at 4uC overnight.
RNA was purified according to the manufacturer protocol. Semi-
quantitative PCR was performed to detect precipitated precursor
miRNAs using SuperScript III One-Step RT-PCR System (Life
Technologies) with primer sets for pre-let-7g, pre-miR-16, and b-
tubulin (ValueGene; see Table S2).
Biotin-pre-miRNA pull-down
Biotinylated pre-let-7g pull-down was performed as previously
described [14] with a few modifications. Streptavadin Dynabeads
(Life Technologies) were washed according to the manufacturer’s
protocol, then blocked with 0.1 mg/ml tRNA for 30 min at room
temperature. The beads were then incubated with biotinylated
pre–let-7g (500 nM) for 15 min, followed by washing. Cell extracts
were lysed in 20 mM Tris pH 7.4, 200 mM NaCl, 2.5 mM
MgCl2, 0.05% NP40, 60 U/ml RNase OUT (Life Technologies),
1 mM DTT, and protease inhibitors (Roche), and added to the
beads for overnight incubation at 4uC. The beads were washed
three times in lysis buffer and the bound proteins were analyzed by
Western blotting with antibodies to Dicer (Abnova, 1:500), Ago2
(Abnova, 1:1000), and TRBP (Abfrontier, 1:1000).
Quantitative RT-PCR
Levels of pre-let-7g in RNA samples from B104 cells under
control and RBM3 knockdown conditions were measured by
quantitative RT-PCR using the GenoExplorer microRNA qRT-
PCR Kit from GenoSensor Corporation (Tempe, AZ). Three
biological replicates were run per condition, with 4 technical
replicates per sample. Ligation and extension of RNAs and real-
time amplification of pre-let-7g and U6 by qPCR with specific and
universal primers were conducted according to the manufacturers
recommendations using their primer sets. The relative levels of
pre-let-7g in control and RBM3 knockdown samples were
calculated using the DDCt method with U6 as the reference.
Quantification of Western blots, Northern blots and
Autoradiograms
Quantification of Northern blot, Western blot, and processing
autoradiograms utilized the Alpha Ease software. Group data
compiled in Excel files and subsequently analyzed for statistical
significance in Prizm (GraphPad).
Supporting Information
Figure S1 Knockdown and overexpression of RBM3 in
the B104 neuronal cell line. (A) Western blot showing RBM3
levels 36 hours after transfection with no siRNA (con), a scrambled
siRNA (scr), a siRNA targeting RBM3 (RBM3), or an expression
construct containing the RBM3 open reading frame downstream of
a CMV promoter in the pcDNA3.1 vector (o/x). b-actin served as a
loading control. Mock transfections were used throughout the study
as introduction of scrambled siRNA induced slight elevations in
RBM3. (B) Northern blots showing pre-let-7g and mature let-7g
(and 5S loading control) in samples from the same treatments shown
in panel a. Expression of mature let-7g was impaired by knockdown
of RBM3 and enhanced by overexpression of RBM3. A slightly
elevated level of let-7g was present in the scrambled siRNA sample,
consistent with a slight elevation of RBM3 levels. (C) Western blots
of RBM3 in triplicate control, knockdown (siRNA) and overex-
pression experiments used for microarray profiling of miRNA
expression, and as part of subsequent Northern blot validation
studies. RBM3 levels were reliably reduced by over 90% by siRNA,
and overexpressed with a CMV promoter-based construct at levels
mimicking induction after cold-shock.
(PDF)
Figure S2 Bidirectional modulation of miRNA expres-
sion by manipulation of RBM3. (A) Upper panels: Northern
blots showing pre-miR-125a and mature miR-125a-5p (and 5S
loading control) in samples from B104 cells under control (con),
RBM3 knockdown (si), and RBM3 overexpression (o/x). Lower
panels: Northern blots showing pre-let-7i and mature let-7i in the
same samples. (B) Northern blot for pre-miR-125a using a probe
complementary to the full sequence; 5S is the loading control.
(PDF)
Figure S3 Cold-shock induction of RBM3 recapitulates
the effects of RBM3 overexpression on miRNA expres-
sion. (A & B) Northern blots showing levels of precursor and
mature forms of let-7g (A) and miR-30b (B) along with 5S RNA
(loading control) in B104 cells under the following conditions:
control (con), RBM3 knockdown (siRNA), RBM3 overexpression
(o/x), and cold-shock (32uC for 24 hrs). Lower panels in (A) show
that the manipulations of RBM3 do not alter levels of tRNAs as
visualized by Northern blotting for tRNA-Lys and ethidium
bromide staining of the corresponding gel. (C) Full Northern blot
of let-7 from Figure 2 of the main text demonstrating that the
enhancement of mature let-7g biogenesis by cold shock requires
RBM3 induction. Relative to cells maintained at 37uC, let-7g is
elevated under conditions of mild hypothermia in control B104
cells, but not in cells transfected with RBM3 siRNA. 5S RNA is
the loading control. Western blots of RBM3 (lower panels) show
induction at 32uC in controls, but greatly attenuated expression at
both temperatures in the siRNA condition. b-actin is the loading
control.
(PDF)
Figure S4 RBM3 regulates levels of Dicer complex
components in HeLa cells. (A & B) Western blots showing
the relative abundance of Dicer, TRBP (A), and Ago2 (B) in Hela
cells after knockdown (si) and overexpression (o/x) of RBM3,
relative to control (con). (C) Western blot showing RBM3
expression after knockdown and overexpression of a myc-tagged
version of RBM3. b-actin was used as a loading control.
(PDF)
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Figure S5 Components of the miRNA processing ma-
chinery are still able to assemble onto exogenous pre-
miRNA after knockdown of RBM3. Lysates of B104 cells
maintained under control conditions (left panels) or transfected
with a siRNA to RBM3 (right panels) were incubated with
biotinylated pre-let-7i or pre-miR-16, followed by retrieval of
bound complexes using streptavadin Dynabeads. Incubation with
beads alone (beads) was used to control for non-specific
associations. Dicer, TRBP, and Ago2 were retrieved in larger
amounts from RBM3 siRNA-treated cells than from controls,
consistent with elevated levels of these factors in the RBM3
knockdown condition.
(PDF)
Figure S6 Knockdown of RBM3 alters the formation of
monosomes and polysomes, and the relative fraction-
ation of pre-miRNPs relative to miRNA processing
factors. (A) RNA-containing complexes in lysates from B104
cells maintained under control conditions (left panels) or
transfected with RBM3 siRNA (right panels) were resolved by
centrifugation through a 15%-55% linear sucrose gradient. The
traces show continuous A260 readings through the gradients; the
top of the gradient is at the left of each trace. The positions of 40S
and 60S ribosomal subunits and 80S monosomes are indicated.
Western blots showing the distribution of the small ribosomal
subunit protein S20 across all fractions collected from the gradient
(2260.5 mL fractions). The solid line insets delineate the set of
complexes resolved by higher resolution gradients. These are
shown in Figure S6B and include pre-miRNA-ribonucleoprotein
complexes. (B) Optimization of the fractionation parameters to
resolve lower molecular (MW) weight ribonucleoprotein particles
(RNPs) reveals an altered fractionation of miRNA precursor-
containing RNPs (pre-miRNPs). Traces of A260 through the 22
fraction (11 mL) gradients show that a set of low MW RNPs is
altered in RBM3 siRNA-transfected (right panels) vs control (left
panels) B104 cells. Major low MW RNP peaks are labeled by the
fraction they correspond to; 40S and 60S ribosomal subunits are
indicated for reference. Northern blots presented in Figure 4 of the
main text are shown below each gradient trace here to show the
distribution and levels of pre-let-7g and mature let-7g in the first 9
fractions of each gradient relative to the A260 trace; fraction 6
(red) contains the peak distribution of TRBP and Ago2.
(PDF)
Figure S7 Immunoprecipitation of miRNA precursors
with RBM3. (A) Gel showing RT-PCR products amplified input
and immunoprecipitate (IP) fractions with primers specific for pre-
miR-16; affinity purified a-RBM3 polyclonal and a pre-immune
IgG control were used in immunoprecipitation reactions. The
results are similar to those presented for pre-let-7g in Figure 4 of
the main text. (B) Gel showing the effects of omitting reverse
transcriptase (RT) from PCR reactions used to detect pre-let-7g in
a-RBM3 immunoprecipitate and input fractions. The pre-let-7g
product is only amplified in each fraction if RT is included.
(PDF)
Table S1 Agilent miRNA array data. Table listing 159
miRNAs showing significant expression changes, out of 216
detected above threshold using Agilent miRNA microarrays, after
knockdown of RBM3 in the B104 neuronal cell line.
(PDF)
Table S2 Oligonucleotides used. Table listing oligonucleo-
tides used in Northern blot, in situ hybridization, RT-PCR, gel
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